Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease

Clinical trial NCT07292012 · RECRUITING

Trial details

NCT number: NCT07292012
Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn Disease (CD)

Start date: 2026-05-11
Primary completion: 2027-11-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.